Approval followed priority review and was based on response rates and duration of response demonstrated in the phase 1b ...

The FDA has granted accelerated approval to zongertinib for pretreated, HER2+ non-squamous NSC lung cancer, based on results ...

Objectives With the growing adoption of virtual consultations in primary care, the need for tailored metrics to evaluate their safety became increasingly urgent. This systematic review seeks to ...

The FDA approved Hernexeos for adults with unresectable or metastatic non-squamous non-small cell lung cancer.

GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...

Patients with bronchiectasis–RA overlap syndrome (BROS) had a 2.09-fold higher mortality risk compared to those with ...

Persistent cough that lasts beyond two weeks should not be ignored. It can be signs of chronic bronchitis, tuberculosis, ...

Rheumatoid arthritis (RA) commonly causes joint damage and fatigue, but it may sometimes cause symptoms that affect your skin ...

Source: Analyst estimates for the quarter provided by FactSet.

Baron Capital highlights biotech and robotic surgery as key growth drivers in Q2. See which stocks surged, which stumbled, ...

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...

TX45 PH-ILD Phase 2 clinical trial is planned to initiate in 2026 to evaluate TX45’s safety and hemodynamic effects in subjects with Pulmonary Hypertension associated with Interstitial Lung Disease ...